TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Open Access
- 18 May 2010
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 17 (5), 481-496
- https://doi.org/10.1016/j.ccr.2010.03.021
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Regulation of FOXO1 by TAK1-Nemo-like Kinase PathwayOnline Journal of Public Health Informatics, 2010
- Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- Contradictory functions of NF-κB in liver physiology and cancerCancer Letters, 2008
- IKK1 and IKK2 cooperate to maintain bile duct integrity in the liverProceedings of the National Academy of Sciences of the United States of America, 2008
- TAK1 is required for the survival of hematopoietic cells and hepatocytes in miceThe Journal of Experimental Medicine, 2008
- A role for IκB kinase 2 in bipolar spindle assemblyProceedings of the National Academy of Sciences of the United States of America, 2007
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences of the United States of America, 2006
- Hepatocellular carcinomaJournal of Hepatology, 2000